{
    "medicine_id": "2793ff4f4ed97e2dca141517a0a55607c1765269",
    "platform_id": "DB06439",
    "metadata": {
        "name": "Bles 50 mg 1 2mL Suspension",
        "composition": "50 mg 1 2mL Tyloxapol",
        "clinical_particulars": {
            "therapeutic_indications": "Tyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus Tyloxapol is administered either through nebulized solution or a stream of oxygen Also investigated for use treatment in cystic fibrosis and pediatric indications",
            "contraindications": {
                "disease": "Acute oral LD50 in 1000 mg kg in mouse and 5000 mg kg in rat",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "It is used as a surfactant to aid liquefaction and removal of mucopurulent containing mucus and pus bronchopulmonary secretions Tyloxapol also blocks plasma lipolytic activity and thus the breakdown of triglyceride rich lipoproteins",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}